Medicenna Therapeutics Corp. announced that Ms. Rosemina Merchant and Dr. Chandrakant Panchal decided not to stand for re-election at the Meeting at its annual and special meeting of shareholders held on September 28, 2023. Ms. Merchant remains the Chief Development Officer of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.07 CAD | +2.99% |
|
+13.11% | +392.86% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+392.86% | 111M | |
+38.36% | 52.5B | |
+36.73% | 39.31B | |
-8.63% | 39.01B | |
+25.46% | 28.2B | |
-11.17% | 26.57B | |
+11.44% | 26.2B | |
+45.09% | 14.15B | |
+32.93% | 12.62B | |
-5.30% | 11.74B |
- Stock Market
- Equities
- MDNA Stock
- News Medicenna Therapeutics Corp.
- Medicenna Therapeutics Corp. Announces Board Resignations